Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers
- PMID: 16651414
- DOI: 10.1158/0008-5472.CAN-06-0031
Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers
Abstract
Medullary breast cancer (MBC) is a rare but enigmatic pathologic type of breast cancer. Despite features of aggressiveness, MBC is associated with a favorable prognosis. Morphologic diagnosis remains difficult in many cases. Very little is known about the molecular alterations involved in MBC. Notably, it is not clear whether MBC and ductal breast cancer (DBC) represent molecularly distinct entities and what genes/proteins might account for their differences. Using whole-genome oligonucleotide microarrays, we compared gene expression profiles of 22 MBCs and 44 grade III DBCs. We show that MBCs are less heterogeneous than DBCs. Whereas different molecular subtypes (luminal A, luminal B, basal, ERBB2-overexpressing, and normal-like) exist in DBCs, 95% MBCs display a basal profile, similar to that of basal DBCs. Supervised analysis identified gene expression signatures that discriminated MBCs from DBCs. Discriminator genes are associated with various cellular processes related to MBC features, in particular immune reaction and apoptosis. As compared with MBCs, basal DBCs overexpress genes involved in smooth muscle cell differentiation, suggesting that MBCs are a distinct subgroup of basal breast cancer with limited myoepithelial differentiation. Finally, MBCs overexpress a series of genes located on the 12p13 and 6p21 chromosomal regions known to contain pluripotency genes. Our results contribute to a better understanding of MBC and of mammary oncogenesis in general.
Similar articles
-
A gene expression signature identifies two prognostic subgroups of basal breast cancer.Breast Cancer Res Treat. 2011 Apr;126(2):407-20. doi: 10.1007/s10549-010-0897-9. Epub 2010 May 21. Breast Cancer Res Treat. 2011. PMID: 20490655
-
Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis.Breast Cancer Res Treat. 2009 Sep;117(2):273-80. doi: 10.1007/s10549-008-0197-9. Epub 2008 Sep 25. Breast Cancer Res Treat. 2009. PMID: 18815879
-
Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.Am J Surg Pathol. 2007 Apr;31(4):501-8. doi: 10.1097/01.pas.0000213427.84245.92. Am J Surg Pathol. 2007. PMID: 17414096
-
Clinical and pathologic aspects of basal-like breast cancers.Nat Clin Pract Oncol. 2008 Mar;5(3):149-59. doi: 10.1038/ncponc1038. Nat Clin Pract Oncol. 2008. PMID: 18212769 Review.
-
The phenotypic spectrum of basal-like breast cancers: a critical appraisal.Adv Anat Pathol. 2007 Sep;14(5):358-73. doi: 10.1097/PAP.0b013e31814b26fe. Adv Anat Pathol. 2007. PMID: 17717437 Review.
Cited by
-
Molecular profiling in breast cancer.Rev Endocr Metab Disord. 2007 Sep;8(3):185-98. doi: 10.1007/s11154-007-9035-3. Rev Endocr Metab Disord. 2007. PMID: 17464566 Review.
-
Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis.Oncoimmunology. 2015 Jun 24;5(1):e1061176. doi: 10.1080/2162402X.2015.1061176. eCollection 2016. Oncoimmunology. 2015. PMID: 26942074 Free PMC article.
-
Hormone Receptor Status May Impact the Survival Benefit Between Medullary Breast Carcinoma and Atypical Medullary Carcinoma of the Breast: A Population-Based Study.Front Oncol. 2021 Jul 6;11:677207. doi: 10.3389/fonc.2021.677207. eCollection 2021. Front Oncol. 2021. PMID: 34295817 Free PMC article.
-
Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.Oncotarget. 2016 Apr 19;7(16):22665-73. doi: 10.18632/oncotarget.8142. Oncotarget. 2016. PMID: 27009810 Free PMC article.
-
Triple-Negative Breast Cancer: Basic Biology and Immuno-Oncolytic Viruses.Cancers (Basel). 2023 Apr 21;15(8):2393. doi: 10.3390/cancers15082393. Cancers (Basel). 2023. PMID: 37190321 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous